Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist.
Corbin, A E
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist. [electronic resource] - Pharmacology, biochemistry, and behavior Feb 1998 - 487-93 p. digital
Publication Type: Journal Article
0091-3057
10.1016/s0091-3057(97)00442-5 doi
Animals
Antipsychotic Agents--pharmacology
Benzimidazoles--pharmacology
Biogenic Monoamines--biosynthesis
Brain Chemistry--drug effects
CHO Cells
Cholinergic Antagonists--pharmacology
Cricetinae
Dopamine Antagonists--pharmacology
Dopamine D2 Receptor Antagonists
Dose-Response Relationship, Drug
Male
Mice
Motor Activity--drug effects
Piperidines--pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Dopamine D3
Signal Transduction--drug effects
Thymidine--metabolism
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist. [electronic resource] - Pharmacology, biochemistry, and behavior Feb 1998 - 487-93 p. digital
Publication Type: Journal Article
0091-3057
10.1016/s0091-3057(97)00442-5 doi
Animals
Antipsychotic Agents--pharmacology
Benzimidazoles--pharmacology
Biogenic Monoamines--biosynthesis
Brain Chemistry--drug effects
CHO Cells
Cholinergic Antagonists--pharmacology
Cricetinae
Dopamine Antagonists--pharmacology
Dopamine D2 Receptor Antagonists
Dose-Response Relationship, Drug
Male
Mice
Motor Activity--drug effects
Piperidines--pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Dopamine D3
Signal Transduction--drug effects
Thymidine--metabolism